Endobronchial Ultrasound Biopsy Market Size Worth USD 1,150.11 Million by 2034 | CAGR: 4.6%

The endobronchial ultrasound biopsy market size is expected to reach USD 1,150.11 million by 2034, according to a new study by Polaris Market Research. The report “Endobronchial Ultrasound Biopsy Market Size, Share, & Industry Analysis Report: By Product, By Procedure, By End Use (Hospitals, ASCs, and Specialty Clinics), and By Region – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The endobronchial ultrasound biopsy market refers to the specialized segment of interventional pulmonology focused on the diagnosis and staging of lung cancer and other thoracic diseases using real-time ultrasound-guided bronchoscopy. The market is witnessing robust momentum due to the escalating demand for minimally invasive diagnostic solutions that offer higher precision and lower complication rates compared to conventional techniques. Rising prevalence of non-small cell lung cancer, coupled with increasing adoption of image-guided diagnostic modalities, is significantly accelerating endobronchial ultrasound biopsy market expansion. The demand is further driven by the growing clinical shift toward early detection protocols and personalized medicine, necessitating highly accurate tissue sampling tools.

Rapid technological developments in EBUS scopes, needles, and integrated ultrasound devices are reshaping the industry landscape, enhancing diagnostic yield and procedural efficiency. The trend toward digitized, AI in medical imaging platforms is opening new opportunities for improved accuracy and workflow optimization. Surgeons and pulmonologists increasingly prefer EBUS biopsy techniques for mediastinal lymph node evaluation, pushing device manufacturers to innovate across the product continuum. Moreover, increased investments in research collaborations, clinical trials, and industry-academic partnerships are creating a fertile ground for advanced product development.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/endobronchial-ultrasound-biopsy-market/request-for-sample

The demand is reinforced by the proliferation of ambulatory surgical centers and their rising procedural volume, reflecting a decentralized healthcare model that prioritizes cost-efficiency without compromising clinical outcomes. Participants are capitalizing on regulatory clearances and commercial launches to penetrate untapped segments, creating strategic opportunities for growth. The evolving diagnostic landscape continues to support the long-term potential of the endobronchial ultrasound biopsy market.

Top of FormEndobronchial Ultrasound Biopsy Market Report Highlights

• By product, in 2024, the EBUS scopes segment held the largest market share owing to its indispensable function in real-time navigation and tissue sampling for thoracic diagnostics.
• Based on end use, the ambulatory surgical center segment is expected to witness the highest CAGR during the forecast period due to increasing procedural volumes, cost efficiency, and favorable reimbursement models.
• In 2024, North America held the largest share due to the region’s high diagnostic awareness.
• The Asia Pacific market is projected to register the highest CAGR during the forecast period, driven by the rising incidence of lung cancer.
• A few global key market players include ACE Medical Devices Pvt. Ltd., Boston Scientific Corporation, Cook Group Incorporated, FUJIFILM Holdings Corporation, GE Healthcare, Koninklijke Philips N.V., Medi-Globe Technologies GmbH, Olympus Corporation, Praxis Medical, Siemens Healthcare Private Limited.

Polaris Market Research has segmented the market report on the basis of product, procedure, end use, and region:

By Product Outlook (Revenue, USD Million, 2020–2034)

• EBUS Scopes
• EBUS Needles
• Ultrasound Processors & Imaging Systems
• Accessories

By Procedure Outlook (Revenue, USD Million, 2020–2034)

• EBUS-Transbronchial Needle Aspiration (EBUS-TBNA)
• EBUS-Guided Biopsy

By End Use Outlook (Revenue, USD Million, 2020–2034)

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics

By Regional Outlook (Revenue, USD Million, 2020–2034)

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America